BROADFIN CAPITAL, LLC Information

237 PARK AVENUE, 9TH FLOOR, NEW YORK, New York, 10017, (212) 808-2463

Report Date: 03/31/2014

Position Statistics

Total Positions 96
New Positions 37
Increased Positions 58
Decreased Positions 31
Positions with Activity 89
Sold Out Positions 11
Total Mkt Value (in $ millions) 934

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.77%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 2.14%
Healthcare 84.72%
Services 4.94%
Technology 0.23%
Transportation 0.55%
Utilities

89 Activity Positions as of 03/31/2014

Company Class Value of Shares ($1,000s) ▲ Change in Value ($1,000s) Change (%) Shares Held
AERIE PHARMACEUTICALS INC COM -8,568 Sold Out 0
ASSEMBLY BIOSCIENCES INC COM -2,934 Sold Out 0
DURATA THERAPEUTICS INC COM -2,846 Sold Out 0
EPIZYME INC COM -2,881 Sold Out 0
NPS PHARMACEUTICALS INC COM -11,636 Sold Out 0
NXSTAGE MEDICAL INC COM -7,435 Sold Out 0
OPHTHOTECH CORP COM -6,197 Sold Out 0
RITE AID CORP COM -3,540 Sold Out 0
ST JUDE MED INC COM -7 Sold Out 0
TARGACEPT INC COM -1,202 Sold Out 0
TORNIER N V SHS -329 Sold Out 0
MELA SCIENCES INC COM NEW 1 1 New 400
CARDICA INC COM 704 -4,546 (86.58) 640,346
DIGIRAD CORP COM 1,124 365 48.11 332,480
NANOSPHERE INC COM 1,370 1,370 New 1,000,000
CARDIOME PHARMA CORP COM NO PAR 1,374 1,374 New 200,000
AMARIN CORP PLC SPONS ADR NEW 1,510 1,510 New 1,000,000
BIOSCRIP INC COM 1,613 1,613 New 220,000
CONCERT PHARMACEUTICALS INC COM 1,648 1,648 New 200,000
BIOTA PHARMACEUTIALS INC COM 1,916 1,916 New 636,700